Search

everythinglearnresearchcommunity

for

Search:↓

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

Exposure to plastics may increase the risk of irregular menstrual cycles and symptoms of hormone imbalance in teenage girls.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Estrogen increases a growth factor in hair cells which might affect hair loss.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Low-level laser therapy may increase hair density in pattern hair loss.

Female pattern hair loss is common and increases with age.

Anemia increases the risk of hair loss in post-COVID-19 survivors.

Finasteride and dutasteride can increase beard thickness in men.

PRP treatment may increase hair density and reduce hair loss, but more research is needed.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Niacin derivatives may increase hair fullness in women with hair loss.

COVID-19 has increased hair loss, but many patients see regrowth within months.

Finasteride 1mg daily effectively increases hair growth and slows hair loss in men with male pattern baldness over two years.

The treatment slightly increased hair growth and was safe for most women.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

Topical finasteride effectively and safely increases hair growth in men with hair loss.

COVID-19 increased hair loss, especially in women, linked to Azithromycin use and symptoms like fatigue and skin irritation.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

Cellcurex™ treatment increased hair growth and thickness but caused pain and bleeding.

Scalp treatments increased hair density and reduced hair loss in Telogen Effluvium patients.

Caloric stress and differentiation increase IRES translation, affecting stem cell function and potential therapies.

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

PRP-based treatments can increase hair density, but results vary among individuals.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

More ethanol increases minoxidil delivery, but too much lowers efficiency.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.